JPS62283929A - Treatment of ginseng and treated product produced thereby - Google Patents

Treatment of ginseng and treated product produced thereby

Info

Publication number
JPS62283929A
JPS62283929A JP61126454A JP12645486A JPS62283929A JP S62283929 A JPS62283929 A JP S62283929A JP 61126454 A JP61126454 A JP 61126454A JP 12645486 A JP12645486 A JP 12645486A JP S62283929 A JPS62283929 A JP S62283929A
Authority
JP
Japan
Prior art keywords
ginseng
treated
medicinal
medicinal ginseng
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61126454A
Other languages
Japanese (ja)
Inventor
Mareyoshi Sawaguchi
希能 澤口
Yutaka Moroishi
裕 諸石
Toshihiko Tomita
俊彦 富田
Ken Noda
謙 野田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Priority to JP61126454A priority Critical patent/JPS62283929A/en
Publication of JPS62283929A publication Critical patent/JPS62283929A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Disintegrating Or Milling (AREA)

Abstract

PURPOSE:To obtain a treated ginseng by disintegrating tissue-cultured ginseng with ultrasonic vibration. CONSTITUTION:Root of ginseng (e.g Panax ginseng, Panax japonicum, etc.) is aseptically cultured to obtain a tissue-culture product, which is treated with ultrasonic vibration (1kHz-1MHz, preferably 10-50kHz) to obtain treated ginseng. The treatment is carried out by dispersing the cultured product in a proper solvent (e.g. water, alcohol such as methanol, ketone such as acetone, polyhydric alcohol such as glycerol, etc.) and irradiating the dispersion with ultrasonic vibration. The treated product contains various active components such as saponins, inorganic salts, flavonoids, etc. The treated product and extract prepared therefrom can be utilized as ginseng preparation or various health foods. Since the active component is released from the cell, it can be quickly absorbed even by taking the disintegrated cell as it is and a sufficiently high drug action can be attained.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、薬用人参の有効成分を効果的に得毛ための薬
用人参の処理方法およびそれにより得屯れる処理物に関
する。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for processing medicinal ginseng to effectively obtain hair from the active ingredients of medicinal ginseng, and a processed product obtained thereby.

(従来の技術) 薬用人参1例えば、オタネ人参(Panax gins
engC,A、 Meyer)、チクセツ人参(Pan
ax japonicusCoA、 Meyer)、ア
メリカ人参(Panax quinquefolium
L、)、三七人参(Panax notoginsen
g (Burk) F。
(Prior art) Medicinal ginseng 1 For example, Panax gins
engC, A, Meyer), Panax ginseng (Pan)
ax japonicus CoA, Meyer), American ginseng (Panax quinquefolium)
L,), Panax notoginsen
g (Burk) F.

H,Chen)、  シベリア人参(E Ieu th
erococcussenticosus)の根は有用
漢方薬として珍重され広(利用されている。
H, Chen), Siberian ginseng (E Ieu th
The root of Erococcus senticosus is prized and widely used as a useful herbal medicine.

薬用人参の薬効としては1強壮、長生、鎮静。The medicinal properties of medicinal ginseng include tonicity, longevity, and sedation.

興奮、利尿作用などが明らかにされている。薬用人参か
ら得られる生薬の薬効主成分は、サポニンとサボゲニン
である。薬用人参から抽出されるサポニンはジンセッサ
イドと称される多数の成分群Ro、 Ra、 Rh、 
Rc、 Rd、 Re、 Rf、 RgおよびRhを含
む。このうち薬効の中心をなすものはRhとRgであり
、それぞれ、鎮静作用および興奮作用を有することが知
られている。
It has been shown to have stimulant and diuretic effects. The main medicinal components of crude drugs obtained from medicinal ginseng are saponin and sabogenin. Saponin extracted from medicinal ginseng consists of many component groups called ginssides: Ro, Ra, Rh,
Contains Rc, Rd, Re, Rf, Rg and Rh. Among these, Rh and Rg play a central role in medicinal effects, and are known to have sedative and stimulant effects, respectively.

薬用人参の有効成分は1通常、上記薬用人参の根を裁断
あるいは粉砕した後、適当な溶媒を用いて冷漫法、加温
抽出法などにより抽出して得られる、使用する溶媒は9
例えば、水、アルコール類。
The active ingredients of medicinal ginseng are 1. Usually, the medicinal ginseng roots are cut or crushed and then extracted using an appropriate solvent using a cold extraction method or a hot extraction method.The solvent used is 9.
For example, water and alcohol.

ケトン類、液状多価アルコール類、あるいはこれらの二
種以上の混合溶媒が目的とする有効成分の種類により適
宜選択される。しかし、このような方法では、有効成分
の抽出率は必ずしも充分ではないため、抽出操作を何度
も繰り返して行う必要がある。加温抽出法を用いると抽
出効率は上がるが、有効成分が熱により加水分解、転移
などにより変化し、薬用人参の生薬としての特性が失わ
れるおそれがある。
Ketones, liquid polyhydric alcohols, or a mixed solvent of two or more thereof are appropriately selected depending on the type of target active ingredient. However, in such a method, the extraction rate of the active ingredient is not necessarily sufficient, so it is necessary to repeat the extraction operation many times. Although the heating extraction method increases the extraction efficiency, the active ingredients may change due to hydrolysis or metastasis due to heat, and there is a risk that medicinal ginseng will lose its properties as a herbal medicine.

上記裁断あるいは粉砕した薬用人参の根を1例えば、超
音波処理にかけてさらに細か(破砕することも考えられ
る。しかし、植物細胞組織壁はかたいため、微生物細胞
のように容易に粉砕することがない。
The above-mentioned cut or crushed medicinal ginseng root may be further finely crushed by, for example, ultrasonication. However, the walls of plant cell tissues are hard, so they cannot be easily crushed like microbial cells. .

(発明が解決しようとする問題点) 本発明は上記従来の問題点を解決するものであり、その
目的とするところは、薬用人参の生薬としての特性を失
わせることなくその有効成分を効果的に得るための処理
方法を提供することにある。
(Problems to be Solved by the Invention) The present invention solves the above-mentioned conventional problems, and its purpose is to effectively extract the active ingredients of medicinal ginseng without losing its properties as a crude drug. The objective is to provide a processing method to obtain the desired results.

本発明の他の目的は、薬用人参の有効成分が変化を受け
ずに含有され、該有効成分を効果的に利用しうる薬用人
参の処理物を提供することにある。
Another object of the present invention is to provide a processed product of medicinal ginseng that contains the active ingredients of medicinal ginseng without being changed and can effectively utilize the active ingredients.

(問題点を解決するための手段および作用)本発明の薬
用人参の処理方法は薬用人参組織培養物を超音波により
破砕することを包含し、そのことにより上記目的が達成
される。
(Means and effects for solving the problems) The method for processing medicinal ginseng of the present invention includes disrupting a medicinal ginseng tissue culture by ultrasonication, thereby achieving the above object.

本発明の薬用人参処理物は薬用人参組織培養物を超音波
により破砕して得られ、そのことにより上記目的が達成
される。
The processed medicinal ginseng product of the present invention is obtained by disrupting a medicinal ginseng tissue culture using ultrasound, thereby achieving the above object.

本発明に用いられる薬用人参には1例えば、オタネ人参
、チクセツ人参(トチバ人参)、アメリカ人参、三七人
参、シベリア人参〔いずれもウコギ科植物〕があり、こ
れらの薬用人参のm織培養物が利用される。
Medicinal ginseng used in the present invention includes, for example, Panax ginseng, Panax ginseng, American ginseng, Panax ginseng, and Siberian ginseng (all of which are plants of the Araliaceae family). is used.

薬用人参の組織培養物(カルス)は9例えば薬用人参の
根を無菌的に培養して得られる。培地としては、ムラシ
ゲ−スクーグ(Murash ige−Skoog)の
培地、ホワイト(Wh i te)の培地、オー、エル
A tissue culture (callus) of medicinal ginseng can be obtained, for example, by aseptically culturing the root of medicinal ginseng. Examples of the culture medium include Murashige-Skoog's medium, White's medium, O, L.

ガンポーグ リンスマイヤー−スクーグ(0,L。Gunpaug Linsmeyer-Skoog (0, L.

Gamborg Linsmaier−3koog)の
培地、ガンスレッド(Gantheret)の培地、ツ
レソケ(Tulecke)の培地。
Gamborg Linsmaier-3koog's medium, Gantheret's medium, Tulecke's medium.

モーレル(Morel)の培地などがある。カルスの培
養を行うには、固体培養、液体培養のいずれもが可能で
ある。例えば、液体培地に無菌空気でエアレーションし
ながらゆっくり攪拌し室温で2〜3ケ月間培養を行うと
、培養液17!あたり10〜30g(乾燥重量)のカル
スが得られる。
Examples include Morel's medium. To culture callus, both solid culture and liquid culture are possible. For example, if a liquid medium is slowly stirred while aerated with sterile air and cultured at room temperature for 2 to 3 months, the culture solution will be 17. 10-30 g (dry weight) of callus is obtained per sample.

本発明に用いられる超音波処理の超音波の振動数(周波
数)は、1kHz〜I MHzである。使用する周波数
により装置の大きさがほぼ決まるため。
The vibration frequency (frequency) of the ultrasonic waves in the ultrasonic treatment used in the present invention is 1 kHz to I MHz. The size of the device is largely determined by the frequency used.

その装置の大きさなどを考慮すると10kHz〜50k
Hzの周波数が好適である。上記周波数の超音波を発射
すると、その基本波のほか2倍波、3倍波などの高調波
や混変調波も生じ、これらも超音波処理に有効に作用し
うると考えられる。
Considering the size of the device, 10kHz to 50k
A frequency of Hz is preferred. When ultrasonic waves of the above frequency are emitted, in addition to the fundamental wave, harmonics such as second and third harmonics and cross-modulation waves are also generated, and it is thought that these can also be effective in ultrasonic processing.

超音波処理に必要な出力は、使用する周波数。The power required for ultrasonication depends on the frequency used.

薬用人参組織培養物や後述の溶媒の量、該溶媒の粘度や
表面張力などにより異なるが、いずれの場合も振動をひ
きおこすのに最低限のレベル(キャビテーションレベル
)を維持できる出力があればよい。出力がキャビテーシ
ョンレベルを下まわると組織培養物の破砕効果が不充分
である。キャビテーションレベルを太き(上まわっても
エネルギー IQ失が大きいだけで出力に比例した効果
は得られない。通常、キャビテーションレベルを2〜3
dB上まわる出力であれば効果的に超音波処理がなされ
る。
Although it varies depending on the medicinal ginseng tissue culture, the amount of the solvent described below, the viscosity and surface tension of the solvent, etc., in any case, it is sufficient to have an output that can maintain the minimum level (cavitation level) to cause vibration. When the power is below the cavitation level, the effect of disrupting the tissue culture is insufficient. Increase the cavitation level (even if you exceed it, the energy IQ loss will be large and you will not get an effect proportional to the output. Usually, increase the cavitation level by 2 to 3)
If the output is higher than dB, ultrasonic processing can be effectively performed.

超音波の出力波形も特に限定されない。方形波や三角波
など立ち上がりの速い波形であるほど小出力でキャビテ
ーションレベルに達するため有利ではあるが、超音波処
理装置の振動子からの超音波の伝達機構などを考慮する
と正弦波であっても充分な効果が得られると考えられる
The output waveform of the ultrasonic wave is also not particularly limited. A waveform that rises quickly, such as a square wave or a triangular wave, is advantageous because it reaches the cavitation level with a small output, but considering the transmission mechanism of the ultrasonic wave from the vibrator of the ultrasonic processing device, even a sine wave is sufficient. It is thought that this effect can be obtained.

本発明により薬用人参の処理を行うには、まず。To process medicinal ginseng according to the present invention, first.

上記薬用人参組織培養物を通常、適当な溶媒に分散させ
これに超音波を照射する。超音波の照射時間は特に限定
されないが1例えば、薬用人参組織培養物(水分86重
量%含有)  100gあたり300Wで10〜60分
、好ましくは20〜30分である。
The medicinal ginseng tissue culture is usually dispersed in a suitable solvent and irradiated with ultrasound. The ultrasonic irradiation time is not particularly limited; for example, it is 10 to 60 minutes, preferably 20 to 30 minutes at 300 W per 100 g of medicinal ginseng tissue culture (containing 86% water by weight).

溶媒としては例えば、水;メタノール、エタノール、プ
ロパツールなどのアルコール類;アセトンなどのケトン
類;プロピレングリコール、ブチレングリコール、グリ
セリンなどの多価アルコール類が用いられる。これら二
種以上の混合溶媒であってもよい。使用する薬用人参組
織培養物を通常の溶媒抽出時のようにあらかじめ乾燥し
ておく必要はなく、むしろ培養物をそのまま超音波処理
に供することが破砕効率の点から好ましい。ただし1例
えば無水アルコールにより破砕物(処理物)からアルコ
ール可溶成分を主として抽出したい場合には水分の混入
を抑えるため、あらかじめ所望の程度に乾燥した組織培
養物を用いる。そのほか。
Examples of solvents used include water; alcohols such as methanol, ethanol, and propatool; ketones such as acetone; and polyhydric alcohols such as propylene glycol, butylene glycol, and glycerin. A mixed solvent of two or more of these may be used. It is not necessary to dry the medicinal ginseng tissue culture to be used in advance as in the case of ordinary solvent extraction, but rather it is preferable from the point of view of crushing efficiency to subject the culture to ultrasonication as it is. However, 1. For example, when it is desired to mainly extract alcohol-soluble components from the crushed material (processed material) using absolute alcohol, a tissue culture that has been dried to a desired degree in advance is used in order to suppress the contamination of water. others.

生薬の紅参のように加熱処理を施した薬用人参成分を得
たいときには2組織培養物をあらかじめ熱湯や水蒸気で
処理することも可能である。
When it is desired to obtain heat-treated medicinal ginseng components such as the herbal medicine red ginseng, it is also possible to pre-treat the two tissue cultures with boiling water or steam.

本発明により、薬用人参組織培養物に超音波処理を施す
と、組織培養物は天然の薬用人参の組繊細胞に比べて細
胞膜が柔らかくて薄いうえ水分含量も高く、細胞のフロ
ッグ体が超音波振動により個々の細胞に分離するため、
容易に破砕される。
According to the present invention, when a ginseng tissue culture is subjected to ultrasonic treatment, the tissue culture has a softer and thinner cell membrane and a higher water content than natural ginseng tissue cells, and the frog bodies of the cells are exposed to ultrasonic waves. Because the vibration separates the cells into individual cells,
easily crushed.

その結果、有効成分が分散溶媒中に散出する。超音波処
理による破砕物を例えば、プレスミルを用いて粉砕し、
超音波処理を繰り返して行うとさらに微細に破砕される
。薬用人参組織培養物の破砕物は、そのまま健康食品な
どの用途に利用されうる。上記繰り返し処理により微細
に粉゛砕された処理物はコロイド状となるため1例えば
これらをそのままピーナツツバターやマーガリンなどの
食品に添加することも容易である。
As a result, the active ingredient is dispersed into the dispersion solvent. For example, the crushed product obtained by ultrasonication is pulverized using a press mill,
If the ultrasonic treatment is repeated, it will be further finely crushed. The crushed product of medicinal ginseng tissue culture can be used as it is for purposes such as health foods. The finely ground processed products obtained by the above-mentioned repeated processing become colloidal, so that they can be easily added to foods such as peanut butter and margarine as they are, for example.

上記方法により溶媒中で超音波処理された処理物は、薬
用人参の有効成分が溶媒中に溶は込んでいるため、これ
を濾過することにより薬用人参成分の抽出液が得られる
。加熱による有効成分の変化を考慮しない場合には加熱
することにより抽出効率を上げることができる。しかし
、細胞成分が糊化するため濾過効率が低下する欠点があ
る。水系溶媒を用いる場合には、得られた抽出液に水と
混和しうる有機溶媒1例えばエタノール、を約50v/
v%程度となるように加えると、澱粉、蛋白質などの細
胞成分や高分子分画が析出する。これを除去すると、サ
ポニン、無機塩、フラボノイドなどを比較的高純度で含
有する溶液が得られる。これら薬用人参の有効成分を含
有する溶液を濃縮すると軟エキス、乾燥エキスなどが得
られる。
Since the processed product subjected to ultrasonic treatment in a solvent by the above method contains the active ingredients of medicinal ginseng dissolved in the solvent, an extract of the medicinal ginseng components can be obtained by filtering this. If changes in active ingredients due to heating are not taken into account, heating can increase extraction efficiency. However, there is a drawback that the filtration efficiency decreases because the cell components become gelatinized. When using an aqueous solvent, add about 50v of a water-miscible organic solvent, such as ethanol, to the obtained extract.
When added at a concentration of about v%, cell components such as starch and protein and polymer fractions are precipitated. When this is removed, a solution containing saponins, inorganic salts, flavonoids, etc. in relatively high purity is obtained. When solutions containing the active ingredients of these medicinal ginseng are concentrated, soft extracts, dry extracts, etc. can be obtained.

本発明によれば、薬用人参組織培養物の細胞が充分に破
砕されるため、その有効成分が充分に細胞外へ散出し、
その結果、高収率で有効成分が得られうる。有効成分を
得るために加熱して抽出するという操作を必要としない
ため薬用人参成分が変化を受けることがない。例えば熱
分解によりサポニンがサポニゲンに変化することが極め
て少ない。天然の薬用人参から有効成分を得る場合には
According to the present invention, the cells of the medicinal ginseng tissue culture are sufficiently disrupted, so that the active ingredients are sufficiently dispersed outside the cells.
As a result, the active ingredient can be obtained in high yield. Since there is no need to heat and extract the active ingredients, the medicinal ginseng ingredients are not affected. For example, conversion of saponin to saponigen by thermal decomposition is extremely rare. When obtaining active ingredients from natural medicinal ginseng.

通常、乾燥品が用いられるが1本発明では2組織培養物
がそのまま利用されるため操作も容易である。
Usually, a dried product is used, but in the present invention, the tissue culture is used as it is, so the operation is easy.

得られる超音波処理物やそこから得られるエキスは、薬
用人参製剤をはじめ各種健康食品に利用される。細胞破
砕物をそのまま服用しても、有効成分が細胞外へ散出し
ているため吸収が速やかであり充分な薬効が得られる。
The resulting ultrasonicated products and extracts obtained therefrom are used in various health foods including medicinal ginseng preparations. Even if the cell lysate is taken as is, the active ingredients are dispersed outside the cells, so absorption is rapid and sufficient medicinal efficacy can be obtained.

本発明は薬用人参に限らすシコン、ツルムラサキ、オウ
レン、オウバクなど組織培養されうる植物に応用されう
る。これら植物の分化されていない細胞の集合体(組織
培養物)を超音波処理することにより容易に破砕物が得
られ、有効成分が容易に利用されうる。
The present invention is not limited to medicinal ginseng, but can be applied to plants that can be tissue cultured, such as ginseng, ginseng, oriental ginseng. By sonicating aggregates (tissue cultures) of undifferentiated cells of these plants, crushed products can be easily obtained, and the active ingredients can be easily utilized.

(実施例) 本発明を実施例につき説明する。(Example) The invention will now be explained with reference to examples.

去隻炭土 オタネ人参を常法により組織培養し薬用人参組織培養物
を得た。この培養物100gに水900m lおよびエ
タノールloom lを加えて、 26ktlz、正弦
波で300Wの超音波を30分間照射した。得られた破
砕物を濾過し濾液を得た。さらに、濾取した破砕物に同
一組成の溶媒を加えて再度抽出を行なった。
A medicinal ginseng tissue culture was obtained by tissue culture of Panax ginseng using a conventional method. 900 ml of water and 1 ml of ethanol were added to 100 g of this culture, and the mixture was irradiated with 300 W ultrasonic waves at 26 kTLZ and a sine wave for 30 minutes. The obtained crushed material was filtered to obtain a filtrate. Furthermore, a solvent of the same composition was added to the crushed material collected by filtration, and extraction was performed again.

抽出液を先に得らI7□゛、−濾液とあわせて濃縮し、
エキスを得た。別に、同様の培養物100gから同一組
成の溶媒(水−エタノール混合液)を用い70℃に加熱
して抽出する操作を10回繰り返して得た抽出液を濃縮
してエキスを得た。この加熱抽出によるエキスの抽出率
を100%とし、上記方法で得られるエキスの抽出効率
を算出した。その結果を下表に示す。
The extract was combined with the filtrate obtained earlier and concentrated.
I got the extract. Separately, an extract was obtained by repeating the operation of extracting 100 g of the same culture by heating it to 70° C. 10 times using a solvent of the same composition (water-ethanol mixture), and concentrating the obtained extract. The extraction efficiency of the extract obtained by the above method was calculated, assuming that the extraction rate of the extract by this heating extraction was 100%. The results are shown in the table below.

尖隻斑主 実施例1と同様に超音波処理を行なって得た処理物を濾
過し、得られた固形成分(ケーキ)をローラーミルで粉
砕した。さらに水900m lおよびエタノールLoo
m lを加えて同一条件で再び超音波処理を行なった。
The treated product obtained by performing ultrasonic treatment in the same manner as in Example 1 was filtered, and the obtained solid component (cake) was pulverized with a roller mill. Additionally, 900 ml of water and ethanol Loo
ml was added and the ultrasonic treatment was performed again under the same conditions.

これを濾過し、濾液を最初に得られた濾液とあわせて濃
縮し、エキスを得た。エキスの抽出効率を下表に示す。
This was filtered, and the filtrate was combined with the first obtained filtrate and concentrated to obtain an extract. The extraction efficiency of the extract is shown in the table below.

次に、同様の方法で得た組織培養物から同一組成の溶媒
を用いて冷浸法により得たエキス(比較例4に相当)と
上記本発明による超音波処理により得られたエキスとを
それぞれ下記の条件で液体クロマトグラフィーにかけた
。それぞれのチャートを第1図および第2図に示す・。
Next, an extract obtained from a tissue culture obtained in a similar manner by a cold soaking method using a solvent of the same composition (corresponding to Comparative Example 4) and an extract obtained by ultrasonication according to the present invention were prepared, respectively. It was subjected to liquid chromatography under the following conditions. The respective charts are shown in Figures 1 and 2.

液体クロマトグラフィーによる分析条件担体 : ポリ
スチレン−ジビニルベンゼン 共重合体 ;粒径7  
μmカラム;150×4.6■φ モービルフェイズ: 7セトニトリル −水−リン酸 
(40:  60  : 0.3)流量: 0.8m 
l /min。
Analysis conditions by liquid chromatography Carrier: Polystyrene-divinylbenzene copolymer; Particle size 7
μm column; 150 x 4.6 ■φ Mobile phase: 7 Setonitrile - Water - Phosphoric acid
(40: 60: 0.3) Flow rate: 0.8m
l/min.

検出波長;210nm 温度(カラム);66℃ 第1図および第2図から本発明により得られるエキスに
は冷浸法で得られるエキスに比べて新たなピークが3ケ
所(第2図1.3および5)に確認されるが、そのピー
ク強度は後述の比較例1〜3に比べて約172〜115
のレベルであり、含有成分がほとんど変性されていない
ことがわかる。
Detection wavelength: 210 nm Temperature (column): 66°C As can be seen from Figures 1 and 2, the extract obtained by the present invention has three new peaks compared to the extract obtained by the cold soaking method (Figure 2, 1.3). and 5), but the peak intensity is about 172 to 115 compared to Comparative Examples 1 to 3 described later.
It can be seen that the contained components are hardly denatured.

χ土炭ユ 実施例2に準じて超音波処理を2度行い、得られた濾液
にエタノールを加え、エタノール濃度を50v/v%と
した。これを6時間室温に放置し、析出する沈澱物を濾
去し、濃縮してエキスを得た。
Ultrasonic treatment was performed twice according to Example 2 of χ Earth Charcoal Yu, and ethanol was added to the obtained filtrate to make the ethanol concentration 50 v/v%. This was left at room temperature for 6 hours, and the precipitate that precipitated was filtered off and concentrated to obtain an extract.

エキスの抽出効率を下表に示す。The extraction efficiency of the extract is shown in the table below.

実施例2と同様に液体クロマトグラフィーにかけたとこ
ろ、新たなピークが3ケ所に確認されたが、そのピーク
強度は後述の比較例1〜3に比べて約172〜115の
レベルであった。
When subjected to liquid chromatography in the same manner as in Example 2, three new peaks were confirmed, but the peak intensities were at a level of about 172 to 115 compared to Comparative Examples 1 to 3 described below.

実隻拠土 溶媒として水を使用したこと以外は実施例2と同様であ
る。実施例2と同様に液体クロマトグラフィーにかけた
ところ、新たなピークが2ケ所に確認されたが、そのピ
ーク強度は後述の比較例1〜3に比べて約172〜11
5のレベルであった。
The procedure was the same as in Example 2 except that water was used as the solid soil solvent. When subjected to liquid chromatography in the same manner as in Example 2, two new peaks were confirmed, but the peak intensities were approximately 172 to 11
It was level 5.

且ぷ」ロー 薬用人参組織培養物をミキサーで粉砕し、実施例1と同
一組成の溶液を用い、2時間沸騰させて抽出を2度行な
った。
A medicinal ginseng tissue culture was pulverized with a mixer, and extracted twice by boiling for 2 hours using a solution having the same composition as in Example 1.

得られたエキスを実施例2と同様に液体クロマトグラフ
ィーにかけた。そのチャートを第・3図に示す。第3図
には新たなピークが6ケ所(1〜6)に確認された。第
3図から、得られた成分は熱により変性を受けていると
考えられる。
The obtained extract was subjected to liquid chromatography in the same manner as in Example 2. The chart is shown in Figure 3. In FIG. 3, six new peaks (1 to 6) were confirmed. From FIG. 3, it is considered that the obtained components were denatured by heat.

、胆較1u 比較例1と同様の方法で薬用人参組織培養物からの抽出
を行い、実施例3に準じてエタノールを加え、 50v
/v%エタノール不溶分を濾去した。得られたエキスを
実施例2と同様に液体クロマトグラフィーにかけたとこ
ろ、比較例1とほぼ同様のチャートが得られた。
, Bile Comparison 1u Extraction from medicinal ginseng tissue culture was performed in the same manner as in Comparative Example 1, and ethanol was added in accordance with Example 3.
/v% ethanol insoluble matter was filtered off. When the obtained extract was subjected to liquid chromatography in the same manner as in Example 2, a chart substantially similar to that in Comparative Example 1 was obtained.

土較斑ユ 水を溶媒したこと以外は比較例1と同様である。land comparison spot yu This was the same as Comparative Example 1 except that water was used as the solvent.

得られたエキスを実施例2と同様に液体クロマトグラフ
ィーにかけたところ、比較例1とほぼ同様のチャートが
得られた。
When the obtained extract was subjected to liquid chromatography in the same manner as in Example 2, a chart substantially similar to that in Comparative Example 1 was obtained.

ル較炭↓ 組織培養物をミキサーで粉砕し、実施例1と同一組成の
溶媒を用い20°Cで24時間浸漬し、冷浸法による抽
出を行なった。得られたエキスの抽出効率を下表に示す
The tissue culture was pulverized using a mixer, immersed in a solvent having the same composition as in Example 1 at 20°C for 24 hours, and extracted by cold soaking. The extraction efficiency of the obtained extract is shown in the table below.

ル較更工 比較例4と同様の方法で薬用人参組織培養物からの抽出
を行い、実施例3に準じてエタノールを加え、 50v
/シ%エタノール不溶分を濾去した。得られたエキスの
抽出効率を下表に示す。
Extraction from medicinal ginseng tissue culture was performed in the same manner as in Comparative Example 4, and ethanol was added in accordance with Example 3.
/% ethanol-insoluble matter was filtered off. The extraction efficiency of the obtained extract is shown in the table below.

止較五l 水を溶媒としたこと以外は比較例4と同様である。得ら
れたエキスの抽出効率を下表に示す。
Comparison 5l Same as Comparative Example 4 except that water was used as the solvent. The extraction efficiency of the obtained extract is shown in the table below.

表 (発明の効果) 本発明によれば、このように、薬用人参の有効成分を効
果的に利用しうる薬用人参処理物が得られる。超音波処
理を行うため加熱処理−を必要とせず、その結果、含有
されるを効成分の変性が極めて少ない。本発明により得
られる処理物はそのまま、あるいは有効成分を抽出して
軟エキスや乾燥エキスとし、各種薬用人参製剤、健康食
品などに利用されうる。本発明方法は、薬用人参に限ら
すm織培養されうる植物にいずれも適用され得る。
Table (Effects of the Invention) According to the present invention, a processed medicinal ginseng product that can effectively utilize the active ingredients of medicinal ginseng can be obtained. Since the ultrasonic treatment is performed, no heat treatment is required, and as a result, there is extremely little denaturation of the active ingredients contained therein. The processed product obtained by the present invention can be used as it is, or after extracting the active ingredients into a soft extract or dry extract, it can be used in various medicinal ginseng preparations, health foods, and the like. The method of the present invention can be applied to any plant that can be cultured in medicinal ginseng.

例えば、シコンやツルムラサキからその有効成分や色素
を効果的に抽出することが可能であり、各種植物からの
有効成分の抽出に応用されうる。
For example, it is possible to effectively extract the active ingredients and pigments from Citrus persimmonica and Prunus elegans, and it can be applied to the extraction of active ingredients from various plants.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、薬用人参組織培養物から冷浸法により得たエ
キスの液体クロマトグラフィーのチャート、第2図は薬
用人参組織培養物を超音波処理して得たエキスの液体ク
ロマトグラフィーのチャート、そして第3図は薬用人参
&IIva培養物を沸騰抽出して得たエキスの液体クロ
マトグラフィーのチャートである。 1〜6・・・新たに生じた成分のピーク。 以上
Figure 1 is a liquid chromatography chart of an extract obtained from a medicinal ginseng tissue culture by cold soaking, and Figure 2 is a liquid chromatography chart of an extract obtained by ultrasonication of a medicinal ginseng tissue culture. FIG. 3 is a liquid chromatography chart of an extract obtained by boiling extraction of a ginseng & IIva culture. 1 to 6...Peaks of newly generated components. that's all

Claims (1)

【特許請求の範囲】 1、薬用人参組織培養物を超音波により破砕することを
包含する薬用人参の処理方法。 2、薬用人参組織培養物を溶媒中に分散し、超音波処理
を行う特許請求の範囲第1項に記載の処理方法。 3、薬用人参組織培養物を超音波により破砕して得られ
る薬用人参処理物。 4、薬用人参組織培養物を溶媒中に分散し、超音波処理
を行って得られる特許請求の範囲第3項に記載の薬用人
参処理物。
[Scope of Claims] 1. A method for processing medicinal ginseng, which includes disrupting a medicinal ginseng tissue culture using ultrasound. 2. The treatment method according to claim 1, wherein the medicinal ginseng tissue culture is dispersed in a solvent and subjected to ultrasonication. 3. A processed medicinal ginseng product obtained by disrupting a medicinal ginseng tissue culture using ultrasound. 4. The processed medicinal ginseng product according to claim 3, which is obtained by dispersing the medicinal ginseng tissue culture in a solvent and subjecting it to ultrasonication.
JP61126454A 1986-05-30 1986-05-30 Treatment of ginseng and treated product produced thereby Pending JPS62283929A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61126454A JPS62283929A (en) 1986-05-30 1986-05-30 Treatment of ginseng and treated product produced thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61126454A JPS62283929A (en) 1986-05-30 1986-05-30 Treatment of ginseng and treated product produced thereby

Publications (1)

Publication Number Publication Date
JPS62283929A true JPS62283929A (en) 1987-12-09

Family

ID=14935619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61126454A Pending JPS62283929A (en) 1986-05-30 1986-05-30 Treatment of ginseng and treated product produced thereby

Country Status (1)

Country Link
JP (1) JPS62283929A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106582985A (en) * 2016-12-13 2017-04-26 郑红芹 Ultramicro wall breaking and smashing method for rhizomatic traditional Chinese medicine
CN107095893A (en) * 2017-06-29 2017-08-29 陕西国际商贸学院 A kind of extracting method of Root of Dunn Tongoloa active material and its application
CN108338359A (en) * 2018-06-25 2018-07-31 上海欣百诺生物科技有限公司 The production technology and application thereof of Stigma Maydis total saponins highly finished product
CN115445738A (en) * 2022-09-22 2022-12-09 上海纳米技术及应用国家工程研究中心有限公司 Preparation method of micro-nano solid powder of whole Chinese herbal medicine root, stem and leaf plants and product thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106582985A (en) * 2016-12-13 2017-04-26 郑红芹 Ultramicro wall breaking and smashing method for rhizomatic traditional Chinese medicine
CN107095893A (en) * 2017-06-29 2017-08-29 陕西国际商贸学院 A kind of extracting method of Root of Dunn Tongoloa active material and its application
CN107095893B (en) * 2017-06-29 2020-07-28 陕西国际商贸学院 Extraction method and application of active substances of panax pseudoginseng
CN108338359A (en) * 2018-06-25 2018-07-31 上海欣百诺生物科技有限公司 The production technology and application thereof of Stigma Maydis total saponins highly finished product
CN115445738A (en) * 2022-09-22 2022-12-09 上海纳米技术及应用国家工程研究中心有限公司 Preparation method of micro-nano solid powder of whole Chinese herbal medicine root, stem and leaf plants and product thereof
CN115445738B (en) * 2022-09-22 2023-11-28 上海纳米技术及应用国家工程研究中心有限公司 Preparation method of micro-nano solid powder of whole plant of root, stem and leaf of Chinese herbal medicine and product thereof

Similar Documents

Publication Publication Date Title
JP5795444B2 (en) Polysaccharide extraction method of higher plants and fungi based on microwave chemical treatment
CN102525853B (en) Compound natural plant extract with spot-removing function and preparation method and application thereof
TWI727159B (en) Uses of orchid leaf callus extract
CN108042433B (en) Whitening antioxidant plant composition, plant composition fermentation liquor, preparation method and application
CN105362116A (en) Comprehensive-effect mask free of chemical addition and preparation method thereof
CN108635308A (en) A kind of moisturizing radiation-resisting whitening skin care item and preparation method thereof
KR101151093B1 (en) Cosmetic composition having anti-inflammation and skin regeneration effect
CN111450227A (en) Plant essential oil for relieving shoulder and neck ache
CN112957379B (en) Method for extracting centella asiatica extract
CN108309873B (en) Activation-balanced conditioning essence
JPS62283929A (en) Treatment of ginseng and treated product produced thereby
CN110833187A (en) Enzyme stock solution and preparation method thereof
US7112344B2 (en) Vapor fraction from seeds of Glycine max (L.)Merr. and composition thereof
JPH0648931A (en) Whitening cosmetic
CN110664700B (en) Composition and application thereof in preparation of product for preventing and treating acne
JP2021169532A (en) Transglutaminase production promoter
KR102143154B1 (en) Manufacturing method of hair loss prevention shampoo containing graviola component extracted in two steps
TWI648054B (en) Hydrolysate of water extract of Asparagus officinalis, preparation method and use thereof
CN107028823A (en) One kind prepares high security, and microbial fermentation processes of radix glycyrrhizae zymotic fluid with whitening and anti-aging effects and products thereof
CN111454326A (en) Anti-wrinkle repair bitter gourd peptide and preparation process thereof
US7282226B2 (en) Vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof
TW201932133A (en) Extracting method of cordyceps cicadae extract and the purpose thereof
DE60316681T2 (en) Vapor fraction of Glycine max (L.) merr. Seeds and corresponding composition
CN113018237B (en) Natural, safe and efficient acne removing gel and preparation method thereof
CN114469845B (en) External preparation using wasp needle liquid and preparation method thereof